GlobeNewsWire · CRMD · November 9, 2026

CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care

Get the app for more

Explore stock news, insights and company research.